Multiple imputation to deal with missing EQ-5D-3L data: Should we impute individual domains or the actual index?

Quality of Life Research

Volumn 24, Issue 4, 2015, Pages 805-815

  Simons, Claire L ^a   Rivero Arias, Oliver ^a   Yu, Ly Mee ^a   Simon, Judit ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

EQ 5D 3L; Missing data; Missing data pattern; Multiple imputation; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; CLINICAL TRIAL (TOPIC); COMPUTER PROGRAM; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DAILY LIFE ACTIVITY; DATA PROCESSING; DECISION MAKING; DEPRESSION; DEVELOPMENT; ECONOMIC EVALUATION; EQ-5D-3L INDEX; ERROR; FEMALE; GLASGOW OUTCOME SCALE; HEALTH STATUS; HUMAN; INTENSIVE CARE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MISSING DATA; OPERATION DURATION; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; SAMPLE SIZE; SCORING SYSTEM; SELF CARE; SIMULATION; SUBARACHNOID HEMORRHAGE; COMPLICATION; COST BENEFIT ANALYSIS; CROSS-SECTIONAL STUDY; EVALUATION STUDY; MIDDLE AGED; PSYCHOLOGY; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA;

COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SUBARACHNOID HEMORRHAGE; SURVEYS AND QUESTIONNAIRES;

EID: 84925511766     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-014-0837-y     Document Type: Article

References (40)

1. Briggs, A., Clark, T., Wolstenholme, J., & Clarke, P. (2003). Missing..presumed at random: Cost-analysis of incomplete data. Health Economics,12(5), 377–392.
2. Manca, A., & Palmer, S. (2005). Handling missing data in patient-level cost-effectiveness analysis alongside randomised clinical trials. Applied Health Economics and Health Policy,4(2), 65–75.
3. Burton, A., Billingham, L. J., & Bryan, S. (2007). Cost-effectiveness in clinical trials: Using multiple imputation to deal with incomplete cost data. Clinical Trials,4(2), 154–161.
4. Grieve, R., Cairns, J., & Thompson, S. G. (2010). Improving costing methods in multicentre economic evaluation: The use of multiple imputation for unit costs. Health Economics,19(8), 939–954.
5. Oostenbrink, J. B., & Al, M. J. (2005). The analysis of incomplete cost data due to dropout. Health Economics,14(8), 763–776.
6. Yu, L. M., Burton, A., & Rivero-Arias, O. (2007). Evaluation of software for multiple imputation of semi-continuous data. Statistical Methods in Medical Research,16(3), 243–258.
7. Faria, R., Gomes, M., Epstein, D., & White, I. R. (2014). A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials. PharmacoEconomics. doi:10.1007/s40273-014-0193-3.
8. Little, R. J. & D. B. Rubin. (2002). Statistical analysis with missing data. 2nd ed. Wiley Series in Probability and Statistics. Hoboken, NJ: Wiley.
9. Noble, S. M., Hollingworth, W., & Tilling, K. (2012). Missing data in trial-based cost-effectiveness analysis: The current state of play. Health Economics,21(2), 187–200.
10. Wood, A. M., White, I. R., & Thompson, S. G. (2004). Are missing outcome data adequately handled? A review of published randomized controlled trials in major medical journals. Clinical Trials,1(4), 368–376.
11. Eekhout, I., de Boer, R. M., Twisk, J. W. R., de Vet, H. C. W., & Heymans, M. W. (2012). Missing data: A systematic review of how they are reported and handled. Epidemiology,23(5), 729–732.
12. EuroQol, G. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy,16, 199–208.
13. Brooks, R. (1996). EuroQol: The current state of play. Health Policy,37(1), 53–72.
14. Horsman, J., Furlong, W., Feeny, D., & Torrance, G. (2003). The health utilities index (HUI): Concepts, measurement properties and applications. Health and Quality of Life Outcomes,1, 54.
15. National Institute for Health and Care Excellence. (2013). Guide to the methods of technology appraisal. London: National Institute for Health and Care Excellence.
16. Ratcliffe, J., Young, T., Longworth, L., & Buxton, M. (2005). An assessment of the impact of informative dropout and nonresponse in measuring health-related quality of life using the EuroQol (EQ-5D) descriptive system. Value Health,8(1), 53–58.
17. Blough, D. K., Ramsey, S., Sullivan, S. D., & Yusen, R. (2009). The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery. Health Economics,18(1), 91–101.
18. Szende, A., M. Oppe, & N. Devlin.(2007). EQ-5D value sets: Inventory, comparative review and user guide. A. Szende, M. Oppe, and N. Devlin. (Eds.) Dordrecht: Springer.
19. StataCorp. Stata Statistical Software. (2011). Stata Press: College Station. TX: StataCorp LP.
20. Molyneux, A., Kerr, R., Stratton, I., Sandercock, P., Clarke, M., Shrimpton, J., et al. (2002). International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: A randomised trial. Lancet,360(9342), 1267–1274.
21. Jennett, B., & Bond, M. (1975). Assessment of outcome after severe brain damage. Lancet,1(7905), 480–484.
22. van Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J., & van Gijn, J. (1988). Interobserver agreement for the assessment of handicap in stroke patients. Stroke,19(5), 604–607.
23. EuroQol Research Foundation (2014). Available from http://www.euroqol.org/. [Accessed 14 September 2014].
24. Van Buuren, S., Brand, J. P. L., Groothuis-Oudshoorn, C. G. M., & Rubin, D. B. (2006). Fully conditional specification in multivariate imputation. Journal of Statistical Computation and Simulation,76(12), 1049–1064.
25. Fairbank, J., Frost, H., Wilson-MacDonald, J., Yu, L. M., Barker, K., & Collins, R. (2005). Spine stabilisation trial. Randomised controlled trial to compare surgical stabilisation of the lumbar spine with an intensive rehabilitation programme for patients with chronic low back pain: The MRC spine stabilisation trial. BMJ,330(7502), 1233.
26. Trial Group, K. A. T. (2009). The Knee Arthroplasty Trial (KAT) design features, baseline characteristics, and two-year functional outcomes after alternative approaches to knee replacement. The Journal of Bone and Joint Surgery,91(1), 134–141.
27. Rivero-Arias, O., Gray, A., Frost, H., Lamb, S. E., & Stewart-Brown, S. (2006). Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain. Spine,31(12), 1381–1387.
28. Kendrick, T., Simons, L., Mynors-Wallis, L., Gray, A., Lathlean, J., Pickering, R., et al. (2006). Cost-effectiveness of referral for generic care or problem-solving treatment from community mental health nurses, compared with usual general practitioner care for common mental disorders: Randomised controlled trial. British Journal of Psychiatry,189, 50–59.
29. Horton, N. J., & Kleinman, K. P. (2007). Much ado about nothing: A comparison of missing data methods and software to fit incomplete data regression models. American Statistician,61(1), 79–90.
30. Harel, O., & Zhou, X. H. (2007). Multiple imputation: Review of theory, implementation and software. Statistics in Medicine,26(16), 3057–3077.
31. White, I. R., Royston, P., & Wood, A. M. (2011). Multiple imputation using chained equations: Issues and guidance for practice. Statistics in Medicine,30(4), 377–399.
32. Benjamini, Y., & Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological),57(1), 289–300.
33. Efron, B. (1979). The 1977 rietz lecture—bootstrap methods—another look at the Jackknife. The annals of Statistics,7(1), 1–26.
34. Kind, P., Hardman, G., & Macran, S. (1999). UK population norms for EQ-5D. UK: Centre for Health Economics, University of York.
35. Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research,22(7), 1717–1727.
36. Konig, H. H., Born, A., Gunther, O., Matschinger, H., Heinrich, S., Riedel-Heller, S. G., et al. (2010). Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disorders. Health and Quality of Life Outcomes,8, 47.
37. Long, J. S. (1997). Regression models for categorical and limited dependent variables. London: Sage.
38. Ramsey, J. B. (1969). Tests for specification errors in classical linear least-squares regression analysis. Journal of the Royal Statistical Society. Series B-Statistical Methodology,31(2), 350–371.
39. Carpenter, J. R., Kenward, M. G., & White, I. R. (2007). Sensitivity analysis after multiple imputation under missing at random: A weighting approach. Statistical Methods in Medical Research,16(3), 259–275.
40. Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., et al. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research,20(10), 1727–1736.